PHARIDAK Trademark

Trademark Overview


On Tuesday, September 30, 2014, a trademark application was filed for PHARIDAK with the United States Patent and Trademark Office. The USPTO has given the PHARIDAK trademark a serial number of 79159760. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, February 1, 2018. This trademark is owned by Novartis AG. The PHARIDAK trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
pharidak

General Information


Serial Number79159760
Word MarkPHARIDAK
Filing DateTuesday, September 30, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, February 1, 2018
Registration Number4771011
Registration DateTuesday, July 14, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics
Translation of Words in MarkThe wording "Pharidak" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, February 1, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, September 12, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Wednesday, September 12, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, December 18, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 25, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, November 25, 2015FINAL DISPOSITION PROCESSED
Wednesday, October 14, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 14, 2015REGISTERED-PRINCIPAL REGISTER
Friday, May 8, 2015NOTIFICATION PROCESSED BY IB
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, April 8, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 23, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 20, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 20, 2015EXAMINER'S AMENDMENT ENTERED
Friday, March 20, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015EXAMINERS AMENDMENT E-MAILED
Friday, March 20, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, March 19, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 19, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 19, 2015ASSIGNED TO LIE
Wednesday, March 11, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 6, 2015REFUSAL PROCESSED BY IB
Wednesday, February 25, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 25, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, February 14, 2015APPLICATION FILING RECEIPT MAILED
Thursday, February 12, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, February 12, 2015REFUSAL PROCESSED BY MPU
Wednesday, February 11, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, February 10, 2015NON-FINAL ACTION WRITTEN
Tuesday, February 10, 2015ASSIGNED TO EXAMINER
Tuesday, February 10, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 6, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, February 5, 2015SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB